Judge Orders Deposition Protocol in Incretin Litigation

, The National Law Journal

   | 0 Comments

Michael Johnson of Johnson Becker in Minneapolis has been named lead counsel for coordinating depositions for plaintiffs alleging that they developed pancreatic cancer as a result of taking one of four incretin-based drugs.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202665851065

Thank you!

This article's comments will be reviewed.